Key result
Postprocedural anticoagulation after primary PCI requires ongoing reevaluation to determine optimal clinical utility.
Answers are grounded in this paper and cite their sources.
Urges clinical caution with post-PCI anticoagulation; leaves open optimal utility for future trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2026) studied this question. Postprocedural anticoagulation after primary percutaneous coronary intervention requires ongoing reevaluation to determine its optimal clinical utility.
Synapse has enriched 10 related papers. Consider them for comparative context: